Clinical Trials Logo

Hypoxia clinical trials

View clinical trials related to Hypoxia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06415799 Completed - Hypoxia Clinical Trials

OM2 Abbreviated Sensor Verification

Start date: February 11, 2024
Phase:
Study type: Observational

The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

NCT ID: NCT06415786 Completed - Hypoxia Clinical Trials

OM2 Motion Verification Study

Start date: March 7, 2024
Phase:
Study type: Observational

The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

NCT ID: NCT06373562 Completed - Hypoxia Clinical Trials

Effect of Hypoxic Exposure on Blood Variables in Elite Wrestlers

Start date: December 2, 2013
Phase: N/A
Study type: Interventional

Twelve male wrestlers of the National Polish Team were observed in the study during the camp. The hypoxia group (n=6) participated in sports training and hypoxic exposure, while the control group (n=6) included wrestlers participating only in sports training. The hypoxic group lived and slept in hypoxic rooms. During the camp, all wrestlers followed the same training schedule and diet. In the blood were determined levels of creatine kinase (CK), C-reactive protein (hsCRP) concentration, nitric oxide (NO), morphology, reticulocytes, lipid profile, and ferritin. Also vascular endothelial growth factor (VEGF, VEGFR2, and VEGFR3), erythropoietin (EPO), angiopoietin (Ang 1, Ang 2), endothelial cell adhesion factor-1 (VCAM-1), Erythropoietin (EPO) and hypoxia-inducible factor 1 (HIF-1). Body weight composition was determined.

NCT ID: NCT06371651 Completed - Oxygen Deficiency Clinical Trials

Creatine and GAA for Brain Oxygenation

CREGAA-OXY
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The main aim of this randomized controlled trial is to evaluate cerebral blood oxygenation after 7-day administration of a creatine-guanidinoacetic acid (GAA) mixture in healthy adults before, during, and after a series of cognitive tests.

NCT ID: NCT06344286 Completed - Clinical trials for Hypoxic-Ischemic Encephalopathy

The Effects of Minimal Enteral Nutrition on Mesenteric Blood Flow and Oxygenation in Neonates With HIE

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effects of minimal enteral nutrition (MEN) on mesenteric blood flow and oxygenation with Doppler USG and Near Infrared Spectroscopy (NIRS) during therapeutic hypo¬thermia (TH) in babies with hypoxic ischemic encephalopathy. The main question it aims to answer is: 1- How do the mesenteric blood flow and oxygenation get affected with MEN during TH? Participants will be either fed with MEN during TH or given placebo.

NCT ID: NCT06318312 Completed - Hypoxia Clinical Trials

Effects of Hypoxia on Cognitive Performance

HYPCOG
Start date: March 20, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine the effects of different hypoxia exposures (FiO2 = 11%, 13%, 15%, and 21%) on cognitive performance in healthy adults. The main questions it aims to answer are: - What is the best hypoxia exposure to improve reaction time, anticipation, attention and memory tasks? - Which hypoxia exposure causes the greatest detriments in cognitive function?

NCT ID: NCT06306950 Completed - Clinical trials for Severe Traumatic Brain Injury

Prioritization of Cerebral Deoxygenation in Severe Traumatic Brain Injury and Mortality Benefit.

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Severe traumatic brain injury with a decrease in cerebral oximetry is associated with multiple impaired systemic microcirculations, more morbidities, and a higher mortality rate. When using the brain as an index organ, interventions to improve brain oxygen delivery may have systemic benefits for these patients.

NCT ID: NCT06264193 Completed - Hypoxia Clinical Trials

The Impact of Hypoxia on the Biochemical and Morphological Parameters of Blood in Rowers.

IHOBMPBR
Start date: November 30, 2014
Phase: N/A
Study type: Interventional

The response to hypoxia is very individual and epending on many aspects, such as the type of training, duration, intensity, or hypoxic stimulus, hypoxia affects the athlete in various ways. The results of this study have shown that 18 days of the LH-TL method does not significantly increase the level of EPO and VEGF in rowers. However, reticulocytes, immature red blood cells, have shown significant differences after 18-d LH-TL between groups. Further research should be carried out to investigate an optimal hypoxic dose and time, which will raise EPO, VEGF, and morphology variables.

NCT ID: NCT06149416 Completed - Healthy Clinical Trials

SpO2 Accuracy of Noninvasive Pulse Oximeter Sensor With Motion Conditions

Start date: May 27, 2023
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to validate the SpO2 accuracy of the Stryker Sustainability Solutions pulse oximetry sensors during motion conditions over the range of 70 -100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry during conditions in which the subject is moving. The end goal is to provide supporting documentation for the SpO2 accuracy validation of the reprocessed sensors with motion indications.

NCT ID: NCT06101654 Completed - Hypoxia Clinical Trials

Accuracy of Evie Ring Pulse Oximeter in Profound Hypoxia

Start date: January 9, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this study was to evaluate the accuracy of pulse oximeters over the range of 70-100% per ISO 80601-2-61:2019. Four devices were placed on each subject with two on each index finger at the base and two on each index finger at the fingertip. SpO2 measurements from these devices were compared to sampling of arterial blood during brief stable oxygen desaturation in healthy volunteers to evaluate the claimed range.